Caricamento...
Distinct peripheral blood molecular signature emerges with successful tacrolimus withdraw in kidney transplant recipients
Tacrolimus (Tac) is an effective anti-rejection agent in kidney transplantation, but its off-target effects make withdrawal desirable. While studies indicate that Tac can be safely withdrawn in a subset of kidney transplant recipients, immune mechanisms that underlie successful vs. unsuccessful Tac...
Salvato in:
| Pubblicato in: | Am J Transplant |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7704683/ https://ncbi.nlm.nih.gov/pubmed/32459070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15979 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|